Details of the Drug
General Information of Drug (ID: DM0LTB2)
| Drug Name |
PT-103
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
Thiourea, N-(5-methyl-2-pyridinyl)-N'-(2-phenylethyl)-; 149486-00-0; PETT Analog 53; PT-103; AC1LJB56; MLS000671915; CHEMBL398765; cid_971434; BDBM1886; DTXSID40164296; MolPort-001-646-260; HMS2692K09; ZINC13519717; STL173974; AKOS001094581; MCULE-7559129905; NCGC00245681-01; SMR000294417; 1-Phenethyl-3-(5-methyl-2-pyridyl)thiourea; 1-(5-methyl-2-pyridyl)-3-phenethyl-thiourea; 1-(5-methylpyridin-2-yl)-3-phenethylthiourea; N-(2-Phenethyl)-N -(2-(5-methylpyridyl))thiourea; N-(5-methyl-2-pyridinyl)-N'-(2-phenylethyl)thiourea
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 271.4 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 3.1 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 4 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||


